valuation

What Is Fair Value under IFRS 13?

Fair value, as defined in IFRS 13, is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. It is an exit price, classified in a three-level input hierarchy.

An exit price, not a privately negotiated hope

IFRS 13 (aligned in substance with US GAAP ASC 820) defines fair value as an exit price on the measurement date, in the principal (or most advantageous) market, using the assumptions market participants would use. It is not "value to the current owner", not a fire-sale, and not automatically the price in a relationship-driven private deal.

The standard forces a hierarchy of inputs:

LevelInputsTypical example
Level 1Unadjusted quoted prices in active markets for identical itemsLiquid listed equity
Level 2Observable inputs other than Level 1Yield curves, comparable multiples with adjustments
Level 3Unobservable inputsPrivate-company DCF, unlisted fund NAVs with significant judgement

Highest-and-best-use and unit-of-account rules can change the conclusion for specialised assets. Non-performance risk is included when measuring liabilities.

How fair value shows up in corporate work

Market value in IVS and fair value in IFRS 13 are close cousins; intrinsic value is a different project (fundamentals to a specific analyst). A control premium that a particular strategic would pay may be excluded from fair value if market participants as a class would not pay it.

Worked illustration (invented Level 3 mark)

A fund holds 18% of invented private company Oak & Wire Lighting. No quote exists. Illustration only.

InputChoice
CalibrationRecent arm's-length primary round 11 months ago at €28m equity value
Current indicationComparable companies median EV/EBITDA 9.0x vs 10.5x at last round; earnings +12%
DCF cross-checkUnlevered DCF EV €41m, equity after net debt €34m
IFRS 13 conclusion (fund view)Equity fair value €32m for 100%; 18% stake €5.8m, Level 3, with a liquidity/marketability adjustment documented
What it is notThe €40m a named strategic whispered on a call (entity-specific synergy)

Investor and M&A relevance

Deal price can exceed or undershoot IFRS 13 fair value because buyers underwrite synergies, scarcity and process dynamics. Boards still need fair value for reporting, option grants, and related-party rules. Funds are judged on fair-value discipline: stale cost, ignoring a down-round, or marking only on hope fails both IFRS 13 and IPEV.

Common mistakes

Limitations

Level 3 measurements are model-dependent. The hierarchy ranks inputs, not methods: a DCF can still be IFRS 13-compliant if it uses market-participant cash flows and discount rates. Disclosure of sensitivities is how users see the uncertainty the single point conceals.

Dazur Perspective

Dazur's deal work is about transaction price, which is allowed to differ from accounting fair value. We still insist that any number labelled fair value can survive IFRS 13's exit-price test: observable evidence first, then a documented Level 3 model, never a marketing round number.

Related terms

Sources